Weighted gene co-expression network analysis reveals key stromal prognostic markers in pancreatic cancer
- PMID: 39738404
- PMCID: PMC11685961
- DOI: 10.1038/s41598-024-82563-9
Weighted gene co-expression network analysis reveals key stromal prognostic markers in pancreatic cancer
Abstract
In recent years, it has been shown that stroma compartment can favor tumor proliferation and aggressiveness. Although extensive research with network analyses such as Weighted Gene Co-expression Network Analysis (WGCNA) has been conducted on pancreatic cancer and its stromal components, WGCNA has not previously been applied to isolate and identify genes associated with the abundance of stroma and survival outcome from bulk RNA data. We investigated the gene expression profile and clinical information of 140 pancreatic ductal adenocarcinoma patients from TCGA. Network analysis was performed using WGCNA and four modules were found to be associated to patients' clinical traits. Specifically, one module of 2459 genes, was associated to stromal sample content. Subsequently, those genes were further analyzed for survival association through log-rank test and Cox regression. HPGDS and ITGA9-AS1 emerged as significant indicators of favorable prognosis while KCMF1 and YARS1 were implicated in poorer prognostic outcomes. Importantly, HPGDS was found to be stromal-specific in the TMA cohort of Human Protein Atlas. Single sample GSEA showed that the stromal module is enriched for stromal signature of Moffitt and Puleo. These findings suggest that we uncovered a stromal specific signature through WGCNA and found putative prognostic markers.
Keywords: Biomarkers; PDAC; Stroma; Survival; WGCNA.
© 2024. The Author(s).
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests.
Figures





Similar articles
-
Weighted gene co-expression network analysis reveals key genes involved in pancreatic ductal adenocarcinoma development.Cell Oncol (Dordr). 2016 Aug;39(4):379-88. doi: 10.1007/s13402-016-0283-7. Epub 2016 May 30. Cell Oncol (Dordr). 2016. PMID: 27240826
-
Transcriptomic Analysis of Laser Capture Microdissected Tumors Reveals Cancer- and Stromal-Specific Molecular Subtypes of Pancreatic Ductal Adenocarcinoma.Clin Cancer Res. 2021 Apr 15;27(8):2314-2325. doi: 10.1158/1078-0432.CCR-20-1039. Epub 2021 Feb 5. Clin Cancer Res. 2021. PMID: 33547202 Free PMC article.
-
Lactate-associated gene MCU promotes the proliferation, migration, and invasion of pancreatic ductal adenocarcinoma.BMC Cancer. 2025 May 21;25(1):913. doi: 10.1186/s12885-025-14319-1. BMC Cancer. 2025. PMID: 40399795 Free PMC article.
-
Identification of candidate miRNA biomarkers for pancreatic ductal adenocarcinoma by weighted gene co-expression network analysis.Cell Oncol (Dordr). 2017 Apr;40(2):181-192. doi: 10.1007/s13402-017-0315-y. Epub 2017 Feb 15. Cell Oncol (Dordr). 2017. PMID: 28205147
-
Gene expression profiling of 1200 pancreatic ductal adenocarcinoma reveals novel subtypes.BMC Cancer. 2018 May 29;18(1):603. doi: 10.1186/s12885-018-4546-8. BMC Cancer. 2018. PMID: 29843660 Free PMC article.
References
-
- Siegel, R. L., Giaquinto, A. N. & Jemal, A. Cancer statistics, 2024. CA A Cancer J. Clinic74, 12–49 (2024). - PubMed
-
- Cancer Facts & Figures 2024. (1930).
-
- Boeck, S., Stieber, P., Holdenrieder, S., Wilkowski, R. & Heinemann, V. Prognostic and therapeutic significance of carbohydrate antigen 19–9 as tumor marker in patients with pancreatic cancer. Oncology70, 255–264 (2006). - PubMed
-
- Daamen, L. A. et al. Postoperative surveillance of pancreatic cancer patients. Eur. J. Surg. Oncol.45, 1770–1777 (2019). - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous